Skip to main content
Journal cover image

A Point-of-Care Test to Measure Tacrolimus Directly from Unprocessed Whole Blood.

Journal articles  - Journal Article
Burrow, DT; Kinnamon, DS; Heggestad, JT; Liu, J; Silverstein, BE; Joh, DY; Harris, M; Ellis, MJ; Hucknall, A; Cendales, LC; Chilkoti, A
Published in: Anal Chem
July 28, 2026

Tacrolimus is a cornerstone immunosuppressant used to prevent graft rejection in solid organ transplant recipients. While effective, tacrolimus therapy must be carefully monitored and managed due to the drug's narrow therapeutic window and variable patient responses to dosing. Overdosing of tacrolimus can lead to opportunistic infections, nephrotoxicity, neurotoxicity, and cancer while under-dosing risks organ rejection. As a result, therapeutic drug monitoring (TDM) of tacrolimus is routinely performed. Current monitoring approaches face significant limitations, including slow (4-8 h or days) turnaround times, complex sample preparation requirements, and reliance on centralized infrastructure that delays critical dosing decisions. Furthermore, emerging evidence shows that the pharmacokinetic exposure parameter best associated with clinical outcomes is the area under the concentration-time curve (AUC). AUC-based monitoring requires sampling patients at multiple time points, which increases the logistical burdens to both patients and providers. Hence, there is an urgent need for a point-of-care test for tacrolimus that can be run at the patient bedside, in outpatient clinics, and eventually in patient homes. Here, we describe a novel point-of-care test, the TAC-D4 POCT, capable of measuring tacrolimus levels directly from whole blood samples without sample preparation steps or expensive analyzers with automated results available in 1 h. Our test helps overcome the current logistical barriers in the clinical management of patients receiving tacrolimus therapy ultimately leading to improved patient adherence, outcomes, and the ability to further personalize dosing regimens. Moreover, the Tac-D4 is highly modular and can be used to monitor clinically significantly biomarkers, such as interleukin-6 and matrix metalloproteinase 3, that complement tacrolimus TDM.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Anal Chem

DOI

EISSN

1520-6882

Publication Date

July 28, 2026

Volume

98

Issue

29

Start / End Page

21173 / 21182

Location

United States

Related Subject Headings

  • Tacrolimus
  • Point-of-Care Testing
  • Point-of-Care Systems
  • Immunosuppressive Agents
  • Humans
  • Drug Monitoring
  • Analytical Chemistry
  • 4004 Chemical engineering
  • 3401 Analytical chemistry
  • 3205 Medical biochemistry and metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Burrow, D. T., Kinnamon, D. S., Heggestad, J. T., Liu, J., Silverstein, B. E., Joh, D. Y., … Chilkoti, A. (2026). A Point-of-Care Test to Measure Tacrolimus Directly from Unprocessed Whole Blood. Anal Chem, 98(29), 21173–21182. https://doi.org/10.1021/acs.analchem.5c07803
Burrow, Damon T., David S. Kinnamon, Jacob T. Heggestad, Jason Liu, Brooke E. Silverstein, Daniel Y. Joh, Matt Harris, et al. “A Point-of-Care Test to Measure Tacrolimus Directly from Unprocessed Whole Blood.Anal Chem 98, no. 29 (July 28, 2026): 21173–82. https://doi.org/10.1021/acs.analchem.5c07803.
Burrow DT, Kinnamon DS, Heggestad JT, Liu J, Silverstein BE, Joh DY, et al. A Point-of-Care Test to Measure Tacrolimus Directly from Unprocessed Whole Blood. Anal Chem. 2026 Jul 28;98(29):21173–82.
Burrow, Damon T., et al. “A Point-of-Care Test to Measure Tacrolimus Directly from Unprocessed Whole Blood.Anal Chem, vol. 98, no. 29, July 2026, pp. 21173–82. Pubmed, doi:10.1021/acs.analchem.5c07803.
Burrow DT, Kinnamon DS, Heggestad JT, Liu J, Silverstein BE, Joh DY, Harris M, Ellis MJ, Hucknall A, Cendales LC, Chilkoti A. A Point-of-Care Test to Measure Tacrolimus Directly from Unprocessed Whole Blood. Anal Chem. 2026 Jul 28;98(29):21173–21182.
Journal cover image

Published In

Anal Chem

DOI

EISSN

1520-6882

Publication Date

July 28, 2026

Volume

98

Issue

29

Start / End Page

21173 / 21182

Location

United States

Related Subject Headings

  • Tacrolimus
  • Point-of-Care Testing
  • Point-of-Care Systems
  • Immunosuppressive Agents
  • Humans
  • Drug Monitoring
  • Analytical Chemistry
  • 4004 Chemical engineering
  • 3401 Analytical chemistry
  • 3205 Medical biochemistry and metabolomics